PimedBio

  • ABOUT US
    About Us

    We create new treatments
    based on cutting-edge approaches.

    • STARTUP STORY
    • HISTORY
    • LEADERSHIP
    • PARTNERSHIP & COLLABORATION
    • LOCATION
  • PLATFORM
    Platform

    We create new treatments
    based on cutting-edge approaches.

    • Platform Technology
  • PIPELINE
    Pipeline

    We create new treatments
    based on cutting-edge approaches.

    • OVERVIEW
    • Oncology
    • IMMUNOLOGY
  • PR
    PR

    We create new treatments
    based on cutting-edge approaches.

    • News
    • Notice
    • IR
  • CAREER
    CAREER

    We create new treatments
    based on cutting-edge approaches.

    • Recruitment notice
    • Join us
EN
  • KR
  • About Us
    • Startup story
    • History
    • Leadership
    • Partnership & Collaboration
    • Location
  • Platform
    • Platform technology
  • Pipeline
    • Overview
    • Oncology
      • PMB212
      • PMB298
      • Discovery of new drug platforms
    • Immunology
      • PMB702
  • PR
    • News
    • Notice
    • IR
  • Career
    • Recruitment notice
    • Join Us

PR

Shaping Tomorrow with
Next-Gen Therapeutics
  • News
  • Notice
  • IR
  • home
  • PR
  • Notice

  • 2026.03.25
    파이메드바이오, 혁신 신약 후보물질 미국 특허 등록 완료
  • 2026.03.09
    제 9회 정기 주주총회
  • 2025.09.01
    파이메드바이오, 차세대 암줄기세포 표적 항암제 ‘PMB212’ 美 FDA 임상 1상 승인
  • 2025.03.12
    제 8회 정기 주주총회
  • 2024.08.15
    파이메드바이오, 존슨앤드존슨(J&J) 글로벌 혁신 네트워크 ‘제이랩스(JLABS)’ 선정
  • 2024.03.13
    제 7회 정기주주총회
  • 2023.12.19
    파이메드바이오_2023 국가신약개발사업 10대 우수과제 선정
  • 2023.10.26
    임시 주주총회 안내
  • 2023.03.14
    제6기 정기주주총회
  • 2022.03.15
    제5기 정기주주총회
1 2

2nd floor, H2233, Healthcare Innovation Park, Bundang Seoul National University Hospital, 172 Dolmaro, Bundang-gu, Seongnam-si, Gyeonggi-do
Tel. +82-31-8039-7240
  • 개인정보처리방침
  • 이메일무단수집거부
Copyright(C) Pimedbio. All Rights Reseved.